BioLife Solutions (BLFS) Misses Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $37.18 +1.34%
Revenue Growth %: +3.3%
Financial Fact:
Cost of product sales: 920.94K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +3.3%
Financial Fact:
Cost of product sales: 920.94K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of ($0.32), $0.11 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $37.7 million versus the consensus estimate of $42.92 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Ledyard Financial Group adds two directors, three retire
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
